-
The city expected the legal challenge and is confident it will prevail, said Ave Maria Brennan, senior counsel of the administrative law division in the city's Law Department.
WSJ: City Sued Over New Cab Rules
-
Even if bad vibes from the French government keep Novartis (nyse: NVS - news - people ) from bidding for French rival Aventis (nyse: AVE - news - people ), it still remains a firm to watch for investors in American drug companies such as Pfizer (nyse: PFE - news - people ) and Merck (nyse: MRK - news - people ), who compete directly with the Swiss giant.
FORBES: Pipeline Preview: Novartis
-
Hagar's show at First Ave. (the club, not the street it's on) was the place to be Sunday night.
FORBES: RNC Notebook
-
CropScience was formed from the merger of Bayer's existing agrochemicals business with the one it bought from Aventis (nyse: AVE - news - people ).
FORBES: Bayer Finds Breaking Up Hard To Do
-
It is across the street from 834 Fifth Ave.
WSJ: Pieces of a Mansion Puzzle on Block
-
It has an office above the Apple Store on 9th Ave and 14th Street in New York.
FORBES: ThingD: The Mystery Startup Everyone Drooled Over At Sun Valley
-
Fine Midtown Indian restaurant with an attractive setting and good lunch-time buffet that make it worth the visit.l Maya -- 1191 First Ave.
FORBES: Fact and Comment
-
But the food, although beautifully presented, isn't as tasty as it looks. l Wilkinson's Seafood -- 1573 York Ave.
FORBES: Fact and Comment
-
It is now the Willie Dixon Blues Heaven Foundation (2120 S Michigan Ave), named for the bassist who wrote most of Chess's hits.
BBC: Chicago's jazz and blues shrines
-
The allergy pill Allegra, from Aventis (nyse: AVE - news - people ), might stop your runny nose but it can also give you a backache.
FORBES: The Baby, The Bathwater And The Medicine Chest
-
In August, Aventis (nyse: AVE - news - people ), which had originally developed pagoclone and had licensed it to Indevus, decided not to exercise its option to develop the drug.
FORBES: Magazine Article
-
Basel, Switzerland-based Novartis (nyse: NVS - news - people ) issued a statement this morning confirming that it has done detailed feasibility studies on a white knight bid for Aventis (nyse: AVE - news - people ), which is the target of a hostile takeover by Sanofi-Synthelabo (nyse: SNY - news - people ).
FORBES: Aventis-Novartis Tie-Up Looks Unlikely